Baker IDI Heart and Diabetes Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Baker IDI Heart and Diabetes Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9359
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Baker IDI Heart and Diabetes Institute (Baker Institute) is a medical research organization that offers diagnosis, prevention, treatment of diabetics and cardiovascular disease. The organization offers clinical services such as diabetes services, weight assessment and management clinic healthy hearts clinic, among others. Its research programs include cellular and molecular biology, diabetic complications, hypertension and cardiac disease, atherothrombosis and metabolism. Baker Institute’s health hub provides education and training, clinics, books, events for public and health professionals, and health matter talks. The institute has partnerships and collaborations with other clinical research centers. Baker Institute is headquartered in Melbourne, Victoria, Australia.

Baker IDI Heart and Diabetes Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Baker IDI Heart and Diabetes Institute, Medical Devices Deals, 2012 to YTD 2018 9
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Crescent Capital Partners Acquires Nucleus Network from Baker Institute 11
Partnerships 12
Imugene Enters into Agreement with Baker IDI Heart & Diabetes Institute 12
AdAlta Enters into Agreement with Baker Institute 13
Baker IDI Heart and Diabetes Institute – Key Competitors 14
Baker IDI Heart and Diabetes Institute – Key Employees 15
Baker IDI Heart and Diabetes Institute – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Nov 01, 2018: Dangerous blood pressure caused by specific signalling in the brain 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Key Facts 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Baker IDI Heart and Diabetes Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Baker IDI Heart and Diabetes Institute, Medical Devices Deals, 2012 to YTD 2018 9
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Crescent Capital Partners Acquires Nucleus Network from Baker Institute 11
Imugene Enters into Agreement with Baker IDI Heart & Diabetes Institute 12
AdAlta Enters into Agreement with Baker Institute 13
Baker IDI Heart and Diabetes Institute, Key Competitors 14
Baker IDI Heart and Diabetes Institute, Key Employees 15
Baker IDI Heart and Diabetes Institute, Other Locations 16

List of Figures
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Baker IDI Heart and Diabetes Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Baker IDI Heart and Diabetes Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DCP Midstream, LP:企業の戦略・SWOT・財務分析
    DCP Midstream, LP - Strategy, SWOT and Corporate Finance Report Summary DCP Midstream, LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bone Therapeutics SA (BOTHE):製薬・医療:M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • ICF International, Inc.:戦略・SWOT・企業財務分析
    ICF International, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICF International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • United Community Banks Inc:企業のM&A・事業提携・投資動向
    United Community Banks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Community Banks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • United Bank Of India:企業の戦略・SWOT・財務分析
    United Bank Of India - Strategy, SWOT and Corporate Finance Report Summary United Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • JACCS Co., Ltd.:企業の戦略・SWOT・財務情報
    JACCS Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary JACCS Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Green Cross Cell Corp (031390)-製薬・医療分野:企業M&A・提携分析
    Summary Green Cross Cell Corp (Green Cross Cell), formerly Innocell Corp, a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offer …
  • Coresa Sa
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Varta Microbattery GmbH:企業の戦略的SWOT分析
    Varta Microbattery GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • KKR & Co. L.P.:企業の戦略・SWOT・財務情報
    KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report Summary KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Glow Energy Public Co Ltd (GLOW)-エネルギー分野:企業M&A・提携分析
    Summary Glow Energy Public Company Limited (Glow Energy), a subsidiary of Engie S.A., is an energy utility company. It generates and supplies electricity to Electricity Generating Authority of Thailand (EGAT). The company also generates and supplies electricity, steam, processed water and chilled wa …
  • MDI Achieve Inc:医療機器:M&Aディール及び事業提携情報
    Summary MDI Achieve Inc (MDI), formerly MDI Technologies Inc is a technology company that designs, develops and commercializes financial and clinical management solutions. The company offers MatrixCare software solutions helps in clinical and resident management, analytics management, financial mana …
  • Alfresa Holdings Corp (2784):企業の財務・戦略的SWOT分析
    Summary Alfresa Holdings Corp (Alfresa) is a wholesale distributor and manufacturer of pharmaceuticals products. The company is engaged in ethical pharmaceuticals wholesaling business which delivers a wide range of products, including diagnostic reagents and medical devices. It delivers self medicat …
  • Capsugel Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the b …
  • Genting Malaysia Berhad:戦略・SWOT・企業財務分析
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas including cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neur …
  • SACI Falabella:企業の戦略・SWOT・財務情報
    SACI Falabella - Strategy, SWOT and Corporate Finance Report Summary SACI Falabella - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Wal-Mart Stores Inc:戦略・SWOT・企業財務分析
    Wal-Mart Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Wal-Mart Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Murata Manufacturing Co., Ltd.:企業の戦略・SWOT・財務情報
    Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Internet Initiative Japan Inc (3774):企業の財務・戦略的SWOT分析
    Internet Initiative Japan Inc (3774) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆